CD19-CD20 bispecific CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-CD20 bispecific CAR T cells, covering 2024-07-16 to 2024-07-16. Get the full timeline:
Most recent: Clinical Trial Update: CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors [Phase 1, Phase 2]